A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy
Conditions
- Multiple Sclerosis (MS)
- Neuromyelitis Optica Spectrum Disorders (NMOSD)
- Autoimmune Encephalitis
- Stiff Person Syndrome
Interventions
- BIOLOGICAL: CD20/BCMA-directed CAR-T cells
Sponsor
Huashan Hospital
Collaborators